In contrast, Kornmann and colleagues [19] reported that 57% (4/7) of pancreatic cancer cases showed immunoreactivity for the IIIc splice variant of FGFR1 (FGFR1 IIIc). The gene discussed is FGFR1; the disease is familial pancreatic carcinoma.